Encapsulating doxorubicin can reduce heart damageDecember 10, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
Health Canada approves ibrutinib for CLLDecember 7, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
NICE reconsiders obinutuzumab for CLLDecember 5, 2014Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
FDA approves first anti-CD19 drugDecember 4, 2014Leukemia, Myelodysplasia, TransplantationPharmacyALL
Drug gets orphan designation for MM & CLL/SLLDecember 3, 2014Lymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyNon-Hodgkin Lymphoma
FDA grants drug orphan designation for AMLDecember 3, 2014Leukemia, Myelodysplasia, TransplantationPharmacyAML
NICE expands use of ESAs in cancer patientsDecember 2, 2014AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacy
CAR T-cell therapy gets breakthrough designationNovember 26, 2014Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL